v3.26.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Shares
Series A common stock warrants
Common Shares
Pre-funded warrants
Additional paid-in capital
Series A common stock warrants
Additional paid-in capital
Accumulated deficit
Series A common stock warrants
Total
Beginning balance at Dec. 31, 2024   $ 288,048 $ 53,076   $ 39,568 $ (367,545)   $ 13,147
Beginning Balance, warrants (in shares) at Dec. 31, 2024     12,910,590          
Beginning Balance (in shares) at Dec. 31, 2024   53,353,984            
Increase (Decrease) in Stockholders' Equity                
Net loss           (20,761)   (20,761)
Share-based compensation         1,351     1,351
Employee stock purchase plan purchases   $ 140           140
Employee stock purchase plan purchases (in shares)   110,289            
Ending balance at Mar. 31, 2025   $ 288,188 $ 53,076   40,919 (388,306)   (6,123)
Ending Balance, warrants (in shares) at Mar. 31, 2025     12,910,590          
Ending Balance (in shares) at Mar. 31, 2025   53,464,273            
Beginning balance at Dec. 31, 2025   $ 352,619 $ 55,649   64,104 (430,603)   $ 41,769
Beginning Balance, warrants (in shares) at Dec. 31, 2025     16,412,925         16,412,925
Beginning Balance (in shares) at Dec. 31, 2025   106,236,344           106,236,344
Increase (Decrease) in Stockholders' Equity                
Net loss           (26,066)   $ (26,066)
Share-based compensation         1,282     1,282
Issuance of common shares, vesting of restricted stock units   $ 480     (480)      
Issuance of common shares, vesting of restricted stock units (in shares)   237,677            
Issuance of common shares, net of issuance costs   $ 10,891           10,891
Issuance of common shares, net of issuance costs (in shares)   5,526,590            
Exercise of Series A common stock warrants, net of issuance costs $ 9,529     $ (1,539)     $ 7,990  
Exercise of Series A common stock warrants, net of issuance costs (in shares) 5,666,666           5,666,666  
Employee stock purchase plan purchases   $ 183           183
Employee stock purchase plan purchases (in shares)   127,140            
Ending balance at Mar. 31, 2026   $ 373,702 $ 55,649   $ 63,367 $ (456,669)   $ 36,049
Ending Balance, warrants (in shares) at Mar. 31, 2026     16,412,925       15,705,662 16,412,925
Ending Balance (in shares) at Mar. 31, 2026   117,794,417           117,794,417